clinical evaluation
Fit for Purpose
September 22 by Tony HitchcockAt Cobra we have worked on the development of both naked plasmid DNA and viral gene therapy products for over 20 years. After some rather extended development times, it has been very rewarding to se...
The Rocky Road to Success
June 03 by Tony HitchcockHaving worked in the development and production of early stage therapeutics for over 30 years I appreciate as much as anyone that this is often a highly challenging environment, not least with regar...
Where is Health Technology Assessment Going?
November 04 by Pharma IQChrissie Fletcher, Director and Head of International Biostatistics at Amgen, talks to Helen Winsor from Pharma IQ, about innovation in clinical design, analysis and reporting. Fletcher disc...